Literature DB >> 10647796

Measles history and atopic diseases: a population-based cross-sectional study.

M Paunio1, O P Heinonen, M Virtanen, P Leinikki, A Patja, H Peltola.   

Abstract

CONTEXT: Many recent cross-sectional studies have suggested that lack of early exposure to communicable diseases, including measles, in affluent countries may have increased rates of atopic disease.
OBJECTIVE: To study the association between natural measles infection and atopy. DESIGN AND
SETTING: Cross-sectional nationwide study in Finland using data gathered between November 1, 1982, and June 30, 1986.
SUBJECTS: A total of 547910 individuals aged 14 months to 19 years who at the time of measles-mumps-rubella (MMR) vaccination had relevant information collected on the occurrence of measles and allergic rhinitis, eczema, and asthma. MAIN OUTCOME MEASURES: Lifetime occurrence of atopic manifestations in subjects who had had measles compared with those who had not, expressed as age-specific and age-adjusted prevalence ratios.
RESULTS: The age-adjusted prevalence ratio of atopic manifestations among those who had had measles (n = 20 690) compared with those who had not (n = 527 220) was 1.32 (95% confidence interval [CI], 1.27-1.36) for eczema, 1.41 (95% CI, 1.33-1.49) for rhinitis, and 1.67 (95% CI, 1.54-1.79) for asthma. The positive association between measles and atopy was evident at all ages, in both urban and rural dwellers, and among subjects with many or few contacts at home or in day care.
CONCLUSIONS: Based on our data, measles and atopy occur more frequently together than expected, which does not support the hypothesis that experiencing natural measles infection offers protection against atopic disease.

Entities:  

Mesh:

Year:  2000        PMID: 10647796     DOI: 10.1001/jama.283.3.343

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

2.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 3.  Pollution and the immune response: atopic diseases--are we too dirty or too clean?

Authors:  D Diaz-Sanchez
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

4.  The early life origins of asthma and related allergic disorders.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

5.  Timing of routine immunisations and subsequent hay fever risk.

Authors:  S A Bremner; I M Carey; S DeWilde; N Richards; W C Maier; S R Hilton; D P Strachan; D G Cook
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

6.  Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination.

Authors:  Clara Amalie Gade Timmermann; Christa Elyse Osuna; Ulrike Steuerwald; Pál Weihe; Lars K Poulsen; Philippe Grandjean
Journal:  Pediatr Allergy Immunol       Date:  2015-05-11       Impact factor: 6.377

7.  Early-life origins of the race gap in men's mortality.

Authors:  David F Warner; Mark D Hayward
Journal:  J Health Soc Behav       Date:  2006-09

Review 8.  Antenatal risk factors, cytokines and the development of atopic disease in early childhood.

Authors:  E K Chung; R L Miller; M T Wilson; S J McGeady; J F Culhane
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01       Impact factor: 5.747

9.  Childhood infections and risk of wheezing and allergic sensitisation at age 7-8 years.

Authors:  Monique Mommers; Gerard M H Swaen; Michaela Weishoff-Houben; Huub Creemers; Hermann Freund; Wolfgang Dott; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  The long arm of childhood: the influence of early-life social conditions on men's mortality.

Authors:  Mark D Hayward; Bridget K Gorman
Journal:  Demography       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.